Beaton Andrea, Aliku Twalib, Dewyer Alyssa, Jacobs Marni, Jiang Jiji, Longenecker Chris T, Lubega Sulaiman, McCarter Robert, Mirabel Mariana, Mirembe Grace, Namuyonga Judith, Okello Emmy, Scheel Amy, Tenywa Emmanuel, Sable Craig, Lwabi Peter
Children's National Health System, Washington DC (A.B., A.D., M.J., J.J., R.M., A.S., C.S.). Gulu University, Uganda (T.A.). Case Western Reserve University, Cleveland, OH (C.T.L.). Uganda Heart Institute, Kampala (S.L., J.N., E.O., E.T., P.L.). INSERM U970 (French National Institute of Health and Medical Research), Paris-Cardiovascular Research Center PARCC, France (M.M.). Joint Clinical Research Centers, Kampala, Uganda (G.M.).
Circulation. 2017 Dec 5;136(23):2233-2244. doi: 10.1161/CIRCULATIONAHA.117.029936. Epub 2017 Sep 27.
Screening echocardiography has emerged as a potentially powerful tool for early diagnosis of rheumatic heart disease (RHD). The utility of screening echocardiography hinges on the rate of RHD progression and the ability of penicillin prophylaxis to improve outcome. We report the longitudinal outcomes of a cohort of children with latent RHD and identify risk factors for unfavorable outcomes.
This was a prospective natural history study conducted under the Ugandan RHD registry. Children with latent RHD and ≥1 year of follow-up were included. All echocardiograms were re-reviewed by experts (2012 World Heart Federation criteria) for inclusion and evidence of change. Bi- and multivariable logistic regression, Kaplan-Meier analysis, and Cox proportional hazards models, as well, were developed to search for risk factors for unfavorable outcome and compare progression-free survival between those treated and not treated with penicillin. Propensity and other matching methods with sensitivity analysis were implemented for the evaluation of the penicillin effect.
Blinded review confirmed 227 cases of latent RHD: 164 borderline and 63 definite (42 mild, 21 moderate/severe). Median age at diagnosis was 12 years and median follow-up was 2.3 years (interquartile range, 2.0-2.9). Penicillin prophylaxis was prescribed in 49.3% with overall adherence of 84.7%. Of children with moderate-to-severe definite RHD, 47.6% had echocardiographic progression (including 2 deaths), and 9.5% had echocardiographic regression. Children with mild definite and borderline RHD showed 26% and 9.8% echocardiographic progression and 45.2% and 46.3% echocardiographic improvement, respectively. Of those with mild definite RHD or borderline RHD, more advanced disease category, younger age, and morphological mitral valve features were risk factors for an unfavorable outcome.
Latent RHD is a heterogeneous diagnosis with variable disease outcomes. Children with moderate to severe latent RHD have poor outcomes. Children with both borderline and mild definite RHD are at substantial risk of progression. Although long-term outcome remains unclear, the initial change in latent RHD may be evident during the first 1 to 2 years following diagnosis. Natural history data are inherently limited, and a randomized clinical trial is needed to definitively determine the impact of penicillin prophylaxis on the trajectory of latent RHD.
筛查超声心动图已成为早期诊断风湿性心脏病(RHD)的一种潜在有力工具。筛查超声心动图的效用取决于RHD的进展速度以及青霉素预防改善预后的能力。我们报告了一组潜伏性RHD儿童的纵向结局,并确定了不良结局的危险因素。
这是一项在乌干达RHD登记处进行的前瞻性自然史研究。纳入了患有潜伏性RHD且随访时间≥1年的儿童。所有超声心动图均由专家根据2012年世界心脏联盟标准重新审查,以确定纳入情况和变化证据。还开展了二元和多变量逻辑回归、Kaplan-Meier分析以及Cox比例风险模型,以寻找不良结局的危险因素,并比较接受青霉素治疗和未接受青霉素治疗者的无进展生存期。采用倾向匹配法和其他匹配方法并进行敏感性分析,以评估青霉素的效果。
盲法审查确认了227例潜伏性RHD病例:164例临界病例和63例确诊病例(42例轻度,21例中度/重度)。诊断时的中位年龄为12岁,中位随访时间为2.3年(四分位间距为2.0 - 2.9年)。49.3%的患儿接受了青霉素预防,总体依从率为84.7%。在中度至重度确诊RHD患儿中,47.6%有超声心动图进展(包括2例死亡),9.5%有超声心动图改善。轻度确诊和临界RHD患儿的超声心动图进展率分别为26%和9.8%,超声心动图改善率分别为45.2%和46.3%。在轻度确诊RHD或临界RHD患儿中,疾病类别更严重、年龄更小以及二尖瓣形态特征是不良结局的危险因素。
潜伏性RHD是一种异质性诊断,疾病结局各异。中度至重度潜伏性RHD患儿预后较差。临界和轻度确诊RHD患儿均有显著的进展风险。尽管长期结局尚不清楚,但潜伏性RHD的初始变化可能在诊断后的前1至2年内明显。自然史数据本身存在局限性,需要进行随机临床试验来明确确定青霉素预防对潜伏性RHD病程的影响。